The new Site Selection Report for Life Sciences Companies in Europe, compiled by KPMG in association with Venture Valuation, explores the when, where and how of successful European expansion. The publication looks beyond site selection to include key work streams involved in successfully commercializing pharmaceutical products in Europe. In the 2018 edition, we identify five key work streams involved in building a successful operating model. This popular site selection analysis compares the attractiveness of different European countries, focusing on the most relevant factors such as innovation, infrastructure, taxation and incentives.
Site Selection Report for Life Sciences Companies in Europe 2018
Would you like to be notified about new reports and other valuable content published by Venture Valuation?